Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circulating tumor necrosis factor‐α levels in non‐alcoholic fatty liver disease: A systematic review and a meta‐analysis
Victoria Potoupni, Maria Georgiadou, Eftychia Chatzigriva, et al.
Journal of Gastroenterology and Hepatology (2021) Vol. 36, Iss. 11, pp. 3002-3014
Closed Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

TNF in the liver: targeting a central player in inflammation
Gisa Tiegs, Andrea Kristina Horst
Seminars in Immunopathology (2022) Vol. 44, Iss. 4, pp. 445-459
Open Access | Times Cited: 109
Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats
Mingyue Zhong, Yan Yan, Hai‐Sheng Yuan, et al.
Food & Function (2022) Vol. 13, Iss. 13, pp. 7287-7301
Closed Access | Times Cited: 71
Nonalcoholic fatty liver disease and hepatocellular carcinoma:Insights in epidemiology, pathogenesis, imaging, prevention and therapy
Stergios A. Pοlyzos, Lampros Chrysavgis, Ilias D. Vachliotis, et al.
Seminars in Cancer Biology (2023) Vol. 93, pp. 20-35
Closed Access | Times Cited: 46
The Role of Tumor Necrosis Factor-Alpha in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease
Ilias D. Vachliotis, Stergios A. Pοlyzos
Current Obesity Reports (2023) Vol. 12, Iss. 3, pp. 191-206
Open Access | Times Cited: 40
Pharmacological therapy of metabolic dysfunction-associated steatotic liver disease-driven hepatocellular carcinoma
Yumin Wang, Joshua S. Fleishman, Tongda Li, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 11
Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle Together
Rossella Maresca, Irene Mignini, Simone Varca, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3278-3278
Open Access | Times Cited: 9
ACLY as a modulator of liver cell functions and its role in Metabolic Dysfunction-Associated Steatohepatitis
Paolo Convertini, Anna Santarsiero, Simona Todisco, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 17
Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease
Patrice Marqués, Vera Francisco, Laura Martínez‐Arenas, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2313-2313
Open Access | Times Cited: 16
Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications
Ilias D. Vachliotis, Athanasios D. Anastasilakis, A. Goulas, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 9, pp. 1702-1720
Closed Access | Times Cited: 23
Association between serum perfluoroalkyl substances concentrations and non-alcoholic fatty liver disease among Korean adults: a cross-sectional study using the National Environmental Health Survey cycle 4
Y. Park, Eui Yup Chung, Chang Ho Chae, et al.
Annals of Occupational and Environmental Medicine (2024) Vol. 36, Iss. 1
Open Access | Times Cited: 4
Exploring the mechanism of dendrobine in treating metabolic associated fatty liver disease based on network pharmacology and experimental validation
Feng Li, Jialin Wu, Ye Zhu, et al.
Hereditas (2024) Vol. 161, Iss. 1
Open Access | Times Cited: 4
Association between liver fibrosis and osteoporosis in adults aged 50 and older: insights from the Bushehr Elderly Health Program
Akbar Soltani, Amirhossein Aghakhani, Hojat Dehghanbanadaki, et al.
Journal of Diabetes & Metabolic Disorders (2025) Vol. 24, Iss. 1
Closed Access
Circulating type IV collagen 7S concentrations are associated with left atrial remodeling indices in patients with atrial fibrillation
Yuki Kuzume, Kosuke Fujibayashi, Kouji Tanaka, et al.
Journal of International Medical Research (2025) Vol. 53, Iss. 2
Open Access
Metabolic-associated fatty liver disease in children: a modern view of the pathogenesis, clinical features, methods of diagnosis and treatment
Marina Yu. Komissarova, R. S. Maltsev, A. M. Filin, et al.
Experimental and Clinical Gastroenterology (2025), Iss. 9, pp. 75-85
Closed Access
Resmetirom: The First Disease‐Specific Treatment for MASH
Ali Mohamed Mousa, Mervat Mahmoud, Ghaida Mubarak AlShuraiaan
International Journal of Endocrinology (2025) Vol. 2025, Iss. 1
Open Access
Impact of Helicobacter pylori-Related Metabolic Syndrome Parameters on Arterial Hypertension
Jannis Kountouras, Apostolis Papaefthymiou, Stergios A. Pοlyzos, et al.
Microorganisms (2021) Vol. 9, Iss. 11, pp. 2351-2351
Open Access | Times Cited: 30
Co-occurrence of non-alcoholic steatohepatitis exacerbates psoriasis associated with decreased adiponectin expression in a murine model
Daiki Takezaki, Shin Morizane, Kenta Ikeda, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
A Novel Antioxidant, Hydrogen-Rich Coral Calcium Alters Gut Microbiome and Bile Acid Synthesis to Improve Methionine-and-Choline-Deficient Diet-Induced Non-Alcoholic Fatty Liver Disease
Hung‐Tsung Wu, Chin-Shiang Tsai, Ting‐Hsing Chao, et al.
Antioxidants (2024) Vol. 13, Iss. 6, pp. 746-746
Open Access | Times Cited: 2
Macrophage‐Hepatocyte Circuits Mediated by Grancalcin Aggravate the Progression of Metabolic Dysfunction Associated Steatohepatitis
Tian Su, Yue He, Min Wang, et al.
Advanced Science (2024) Vol. 11, Iss. 42
Open Access | Times Cited: 2
Update on Non-Alcoholic Fatty Liver Disease-Associated Single Nucleotide Polymorphisms and Their Involvement in Liver Steatosis, Inflammation, and Fibrosis: A Narrative Review
Fajar Dwi Astarini, Neneng Ratnasari, Widya Wasityastuti
Iranian Biomedical Journal (2022) Vol. 26, Iss. 4, pp. 252-268
Open Access | Times Cited: 11
Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents
Apostolis Papaefthymiou, Spyros Potamianos, A. Goulas, et al.
Journal of Crohn s and Colitis (2021) Vol. 16, Iss. 5, pp. 852-862
Closed Access | Times Cited: 13
The tetraspanin transmembrane protein CD53 mediates dyslipidemia and integrates inflammatory and metabolic signaling in hepatocytes
Cassandra B. Higgins, Joshua A. Adams, Matthew H. Ward, et al.
Journal of Biological Chemistry (2022) Vol. 299, Iss. 2, pp. 102835-102835
Open Access | Times Cited: 9
Tumor Necrosis Factor-Alpha and Adiponectin in Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma
Ilias D. Vachliotis, Ioannis Valsamidis, Stergios A. Pοlyzos
Cancers (2023) Vol. 15, Iss. 21, pp. 5306-5306
Open Access | Times Cited: 5
Exploring the Mechanism of Dendrobine in Treating Non-Alcoholic Fatty Liver Disease Based on Network Pharmacology and Experimental Validation
Feng Li, Jialin Wu, Ye Zhu, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
New insights of DsbA-L in the pathogenesis of metabolic diseases
Siqi Li, Jinfa Wan, Zhenyu Peng, et al.
Molecular and Cellular Biochemistry (2024) Vol. 479, Iss. 12, pp. 3293-3303
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top